European Medicines Agency EMA has given positive advice about granting a license for the first vaccine against the Ebola virus called Ervebo. 

This is a big step against the deadly virus which kills thousands of people every year. This vaccine can protect people in especially in risk areas. The vaccine has been tested in various clinical trials in Africa, Europe and the United States.

Due to the current Ebola outbreak, a ‘conditional permit’ has been recommended for this Ebola vaccine. The decision was made by the European Medicines Agency EMA in collaboration with the World Health Organization and the African national registration authorities, as the vaccine is effective in the current outbreak in the Democratic Republic of Congo.